Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 37,591Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Vyxeos

PharmaCompass

01

Brand Name : Vyxeos

Daunorubicin

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Vyxeos

arrow
euroPLX 86 Munich
Not Confirmed

Daunorubicin

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 121

2019 Revenue in Millions : 121

Growth (%) : 0

blank

02

Brand Name : Vyxeos

Daunorubicin

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Vyxeos

arrow
euroPLX 86 Munich
Not Confirmed

Daunorubicin

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 134

2020 Revenue in Millions : 121

Growth (%) : 11

blank

03

Brand Name : Vyxeos

Daunorubicin

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Vyxeos

arrow
euroPLX 86 Munich
Not Confirmed

Daunorubicin

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 128

2021 Revenue in Millions : 134

Growth (%) : -5

blank

04

Brand Name : Vyxeos

Daunorubicin

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Vyxeos

arrow
euroPLX 86 Munich
Not Confirmed

Daunorubicin

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 147

2022 Revenue in Millions : 128

Growth (%) : 15

blank

05

Brand Name : Vyxeos

Daunorubicin

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Vyxeos

arrow
euroPLX 86 Munich
Not Confirmed

Daunorubicin

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 121

2018 Revenue in Millions : 101

Growth (%) : 20

blank